Artificial intelligence and machine learning in nephropathology.

Artificial intelligence (AI) for the purpose of this review is an umbrella term for technologies emulating a nephropathologist's ability to extract information on diagnosis, prognosis, and therapy responsiveness from native or transplant kidney biopsies. Although AI can be used to analyze a wide variety of biopsy-related data, this review focuses on whole slide images traditionally used in nephropathology. AI applications in nephropathology have recently become available through several advancing technologies, including (i) widespread introduction of glass slide scanners, (ii) data servers in pathology departments worldwide, and (iii) through greatly improved computer hardware to enable AI training. In this review, we explain how AI can enhance the reproducibility of nephropathology results for certain parameters in the context of precision medicine using advanced architectures, such as convolutional neural networks, that are currently the state of the art in machine learning software for this task. Because AI applications in nephropathology are still in their infancy, we show the power and potential of AI applications mostly in the example of oncopathology. Moreover, we discuss the technological obstacles as well as the current stakeholder and regulatory concerns about developing AI applications in nephropathology from the perspective of nephropathologists and the wider nephrology community. We expect the gradual introduction of these technologies into routine diagnostics and research for selective tasks, suggesting that this technology will enhance the performance of nephropathologists rather than making them redundant.

Physician-Friendly Machine Learning: A Case Study with Cardiovascular Disease Risk Prediction.

Machine learning is often perceived as a sophisticated technology accessible only by highly trained experts. This prevents many physicians and biologists from using this tool in their research. The goal of this paper is to eliminate this out-dated perception. We argue that the recent development of auto machine learning techniques enables biomedical researchers to quickly build competitive machine learning classifiers without requiring in-depth knowledge about the underlying algorithms. We study the case of predicting the risk of cardiovascular diseases. To support our claim, we compare auto machine learning techniques against a graduate student using several important metrics, including the total amounts of time required for building machine learning models and the final classification accuracies on unseen test datasets. In particular, the graduate student manually builds multiple machine learning classifiers and tunes their parameters for one month using scikit-learn library, which is a popular machine learning library to obtain ones that perform best on two given, publicly available datasets. We run an auto machine learning library called auto-sklearn on the same datasets. Our experiments find that automatic machine learning takes 1 h to produce classifiers that perform better than the ones built by the graduate student in one month. More importantly, building this classifier only requires a few lines of standard code. Our findings are expected to change the way physicians see machine learning and encourage wide adoption of Artificial Intelligence (AI) techniques in clinical domains.